Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.

Biotechnology

Amber Bio

This department focuses on overseeing the development and management of the platform's capabilities and functions.

Development and Platform

This department focuses on the design and development of biological systems and structures.

Bioarchitecture

This department focuses on advancing scientific knowledge and developing innovative solutions in various fields, particularly through machine learning and other technologies.

Research and Development

This department oversees organizational governance and strategic direction.

Governance Council

This department focuses on designing and innovating biological structures and systems.

Bioarchitecture Division

This department oversees the strategic direction and governance of the organization.

People (2)

Jobs (0)

Other teams

Bioarchitecture

Research and Development

Governance Council

Bioarchitecture Division

Executive Leadership